Literature DB >> 24303458

Low ADAMTS-13 in plavix induced thrombotic thrombocytopenic purpura.

Long Bao Cao1, Christopher Jones, Assad Movahed.   

Abstract

Thrombotic thrombocytopenia purpura (TTP) was first described in 1924 as a "pathologic alteration of the microvasculature, with detachment or swelling of the endothelium, amorphous material in the sub-endothelial space, and luminal platelet aggregation leading to compromise of the microcirculation". Ticlopidine induced TTP has been highly associated with autoimmune induced reduction in ADAMTS-13 activity. These findings, to a lesser extent, have also been found in clopidogrel induced TTP. We report a case of clopidogrel associated TTP in a patient that presented with acute stroke, renal failure, and non-ST elevation myocardial infarction.

Entities:  

Keywords:  Antiplatelet therapy; Plavix; Thrombotic thrombocytopenic purpura

Year:  2013        PMID: 24303458      PMCID: PMC3845918          DOI: 10.12998/wjcc.v1.i1.31

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  8 in total

1.  Thrombotic thrombocytopenic purpura and clopidogrel--a need for new approaches to drug safety.

Authors:  A J Wood
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

2.  Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention.

Authors:  C L Bennett; C J Davidson; D W Raisch; P D Weinberg; R H Bennett; M D Feldman
Journal:  Arch Intern Med       Date:  1999-11-22

3.  Clopidogrel versus ticlopidine after intracoronary stent placement.

Authors:  P B Berger; M R Bell; C S Rihal; H Ting; G Barsness; K Garratt; V Bellot; V Mathew; S Melby; L Hammes; D Grill; D R Holmes
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

4.  Thrombotic thrombocytopenic purpura associated with clopidogrel.

Authors:  C L Bennett; J M Connors; J M Carwile; J L Moake; W R Bell; S R Tarantolo; L J McCarthy; R Sarode; A J Hatfield; M D Feldman; C J Davidson; H M Tsai
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

5.  Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases.

Authors:  C L Bennett; P D Weinberg; K Rozenberg-Ben-Dror; P R Yarnold; H C Kwaan; D Green
Journal:  Ann Intern Med       Date:  1998-04-01       Impact factor: 25.391

6.  Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; L Rice; R Sarode; T W Chow; J L Moake
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

7.  Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.

Authors:  S R Steinhubl; W A Tan; J M Foody; E J Topol
Journal:  JAMA       Date:  1999-03-03       Impact factor: 56.272

Review 8.  Clopidogrel and thrombotic thrombocytopenic purpura: no clear case for causality.

Authors:  Navneet S Majhail; Alan E Lichtin
Journal:  Cleve Clin J Med       Date:  2003-05       Impact factor: 2.321

  8 in total
  1 in total

1.  A Rare Case of Thrombotic Thrombocytopenic Purpura Caused by Pancreatitis and Clopidogrel.

Authors:  Muhammad Shabbir Rawala; S Tahira Shah Naqvi; Muhammad Yasir Khan; Amr El Toukhy
Journal:  Am J Case Rep       Date:  2018-10-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.